Over-the-counter (OTC) derivatives
OTC Derivatives Clearing Summit Europe: Corporates could be source of eligible assets for clearing
Cash-rich corporates could replace capital-constrained dealers as providers of collateral transformation services, according to one asset manager
Rule changes make it harder for small firms to use CCPs - Risk.net poll
Esma's decision to make indirect clearing an optional service could leave smaller firms without clearing access, according to a poll of Risk.net readers
JSCC reviews capital threshold for clearing membership
Japan’s central counterparty proposes a 20-fold lower capital threshold for membership for it to qualify as a recognised clearing house under US rules; it also started successfully clearing yen interest rate swaps as of last week
CFTC’s clearing timeline prompts backloading "meltdown"
A re-reading of the CFTC's phase-in rules for central clearing is prompting alarm among buy- and sell-side firms
Time running out for buy-side clearing docs negotiation, dealers warn
Buy-side firms need to begin negotiating OTC clearing documentation now or risk being forced to adopt one-size-fits-all standard templates
RIP OTC: Swap futures gaining buy-side fans
RIP OTC: Swap futures gaining buy-side fans
Section 716: The do-nothing approach
The do-nothing approach
Into Africa: Building a sub-Saharan OTC market
Building a sub-Saharan OTC market
Client clearing: Soaring volumes disguise scary workload
Not clear yet
Gazprom Marketing & Trading: Powering up for clearing
Powering up for clearing
Scoach and Euwax feel the pressure
Feeling the pressure
Isda: understanding Dodd-Frank
Cause and effect
Esma backtracks on indirect clearing
Final rules remove two controversial proposals, but revive regulators' concerns about access to clearing for small firms
Indirect clearing to be overhauled in final Esma rules
Indirect clearing will not be compulsory, sources say – and a controversial 30-day guarantee for indirect clients will also be removed
OTC trade sizes could shrink under Mifid reporting rules
Market-makers will be uncomfortable taking on less liquid trades if instant reporting is required, warns a panel at Isda's European conference
CME’s new swap future uses Goldman Sachs patent
Licensing agreement could be worth up to 20% of revenues from patented contract, and is seen as an attempt by Goldman Sachs to hedge its bets as new rules threaten OTC market profits
European OTC clearing documentation faces delay
Complications over close-out mechanisms and segregation models will delay the European addendum by up to three months, say dealers
Risk interdealer rankings 2012: Dealers
Humps, back-downs and whales
Risk interdealer rankings 2012: Brokers
Calm before the storm
New Isda protocol may not fix business conduct bottleneck
Dealers hope to comply with new business conduct rules by amending thousands of Isda master agreements – but a standardised protocol published last month is expected to leave some clients cold
Knight Capital losses spur focus on algo risk management
A dark Knight for algos
Fingerprint, aggregation fears hit swap dealer countdown
Prints and be damned
